Retatrutide is a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By stimulating these receptors, https://margievogu467537.liberty-blog.com/36283705/setmelanotide-a-promising-new-treatment-for-obesity